162 related articles for article (PubMed ID: 10953190)
1. Long-term interferon beta-1b therapy for MS: is routine thyroid assessment always useful?
Monzani F; Caraccio N; Casolaro A; Lombardo F; Moscato G; Murri L; Ferrannini E; Meucci G
Neurology; 2000 Aug; 55(4):549-52. PubMed ID: 10953190
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis.
Monzani F; Caraccio N; Meucci G; Lombardo F; Moscato G; Casolaro A; Ferdeghini M; Murri L; Ferrannini E
Eur J Endocrinol; 1999 Oct; 141(4):325-31. PubMed ID: 10526243
[TBL] [Abstract][Full Text] [Related]
3. Discordant effect of IFN-beta1a therapy on anti-IFN antibodies and thyroid disease development in patients with multiple sclerosis.
Monzani F; Meucci G; Caraccio N; Saviozzi M; Casolaro A; Moscato G; Lombardo F; Mosti S; Scagnolari C; Bruschi F; Antonelli G; Ferrannini E; Murri L
J Interferon Cytokine Res; 2002 Jul; 22(7):773-81. PubMed ID: 12184915
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis.
Rotondi M; Oliviero A; Profice P; Mone CM; Biondi B; Del Buono A; Mazziotti G; Sinisi AM; Bellastella A; Carella C
J Endocrinol Invest; 1998 Dec; 21(11):748-52. PubMed ID: 9972674
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a or 1b therapy: predictive factors of thyroid disease development and duration.
Caraccio N; Dardano A; Manfredonia F; Manca L; Pasquali L; Iudice A; Murri L; Ferrannini E; Monzani F
J Clin Endocrinol Metab; 2005 Jul; 90(7):4133-7. PubMed ID: 15811929
[TBL] [Abstract][Full Text] [Related]
6. Serum thyroglobulin: an early indicator of autoimmune post-partum thyroiditis.
Parkes AB; Black EG; Adams H; John R; Richards CJ; Hall R; Lazarus JH
Clin Endocrinol (Oxf); 1994 Jul; 41(1):9-14. PubMed ID: 8050135
[TBL] [Abstract][Full Text] [Related]
7. Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS.
Durelli L; Ferrero B; Oggero A; Verdun E; Ghezzi A; Montanari E; Zaffaroni M;
Neurology; 2001 Oct; 57(8):1363-70. PubMed ID: 11673572
[TBL] [Abstract][Full Text] [Related]
8. Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis.
Daniels GH; Vladic A; Brinar V; Zavalishin I; Valente W; Oyuela P; Palmer J; Margolin DH; Hollenstein J
J Clin Endocrinol Metab; 2014 Jan; 99(1):80-9. PubMed ID: 24170099
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis, interferon beta and clinical thyroid dysfunction.
Kreisler A; de Seze J; Stojkovic T; Delisse B; Combelles M; Vérier A; Hautecoeur P; Vermersch P;
Acta Neurol Scand; 2003 Feb; 107(2):154-7. PubMed ID: 12580868
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?
Verdun E; Isoardo G; Oggero A; Ferrero B; Ghezzi A; Montanari E; Zaffaroni M; Durelli L;
J Interferon Cytokine Res; 2002 Feb; 22(2):245-55. PubMed ID: 11911808
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.
Carella C; Mazziotti G; Morisco F; Manganella G; Rotondi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
J Clin Endocrinol Metab; 2001 May; 86(5):1925-9. PubMed ID: 11344186
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease.
Rotondi M; Mazziotti G; Biondi B; Manganella G; Del Buono AD; Montella P; di Cristofaro M; Di Iorio G; Amato G; Carella C
J Endocrinol Invest; 2000 May; 23(5):321-4. PubMed ID: 10882151
[TBL] [Abstract][Full Text] [Related]
13. Awareness of biotin: A growing problem in clinical practice.
Ruiz-Ginés MÁ; Ruiz-Ginés JA; Rodríguez González D; Agudo-Macazaga M; Lorenzo-Lozano MC
Endocrinol Diabetes Nutr (Engl Ed); 2020 Jan; 67(1):71-73. PubMed ID: 31387845
[No Abstract] [Full Text] [Related]
14. Occurrence of thyroid autoimmunity in relapsing remitting multiple sclerosis patients undergoing interferon-beta treatment.
Martinelli V; Gironi M; Rodegher M; Martino G; Comi G
Ital J Neurol Sci; 1998 Apr; 19(2):65-7. PubMed ID: 10935838
[TBL] [Abstract][Full Text] [Related]
15. Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study.
Durelli L; Ferrero B; Oggero A; Verdun E; Ghezzi A; Montanari E; Zaffaroni M;
J Clin Endocrinol Metab; 2001 Aug; 86(8):3525-32. PubMed ID: 11502774
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.
Fernandez-Soto L; Gonzalez A; Escobar-Jimenez F; Vazquez R; Ocete E; Olea N; Salmeron J
Arch Intern Med; 1998 Jul; 158(13):1445-8. PubMed ID: 9665354
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Interferon Beta-1b Therapy on Thyroid Function and Autoimmunity Among COVID-19 Survivors.
Lui DTW; Hung IFN; Lee CH; Lee ACH; Tam AR; Pang P; Ho TY; Cheung CYY; Fong CHY; Law CY; To KKW; Lam CW; Chow WS; Woo YC; Lam KSL; Tan KCB
Front Endocrinol (Lausanne); 2021; 12():746602. PubMed ID: 34659128
[TBL] [Abstract][Full Text] [Related]
18. More than adequate iodine intake may increase subclinical hypothyroidism and autoimmune thyroiditis: a cross-sectional study based on two Chinese communities with different iodine intake levels.
Teng X; Shan Z; Chen Y; Lai Y; Yu J; Shan L; Bai X; Li Y; Li N; Li Z; Wang S; Xing Q; Xue H; Zhu L; Hou X; Fan C; Teng W
Eur J Endocrinol; 2011 Jun; 164(6):943-50. PubMed ID: 21444648
[TBL] [Abstract][Full Text] [Related]
19. Thyroid autoimmunity in patients with hyperprolactinemia: an observational study.
Onal ED; Saglam F; Sacikara M; Ersoy R; Cakir B
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):48-52. PubMed ID: 24728164
[TBL] [Abstract][Full Text] [Related]
20. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
